Presentation at 2021 American Society of Clinical Oncologists (ASC0) Annual Meeting
Presentation: Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies
Presenter: Julius Strauss, MD, National Cancer Institute
Session: Developmental Therapeutics—Immunotherapy
Date: June 7, 2021
Time: 3:00 – 6:00 PM ET
Receive Email Alerts
Join our mailing list to receive the latest news and updates from our team.
